Eton Pharmaceuticals (ETON) Cash & Equivalents (2017 - 2026)
Eton Pharmaceuticals' Cash & Equivalents was $26.85 million in Q2 2026, up 5.8% from $25.38 million a year earlier.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Eton Pharmaceuticals came in at $25.94 million, up 73.7% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $14.94 million in FY2024 (-30.2%), $21.39 million in FY2023 (+31.2%), $16.31 million in FY2022 (+13.2%) and $14.41 million in FY2021 (-32.4%).
- Quarterly Cash & Equivalents has moved between $13.38 million (Q3 2022) and $37.12 million (Q3 2025) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in five of the last seven quarters, with growth averaging 24.6%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2021 (growth of 209.7%); the worst was Q3 2022 (a decline of 41.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Eton Pharmaceuticals | 1.95 Bn | 1.82 Bn | 44.30 Mn | 55.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 55.63 Mn |
| Jun 30, 2026 | 26.85 Mn |
| Mar 31, 2026 | 19.66 Mn |
| Dec 31, 2025 | 25.94 Mn |
| Sep 30, 2025 | 37.12 Mn |
| Jun 30, 2025 | 25.38 Mn |
| Mar 31, 2025 | 17.42 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Sep 30, 2024 | 20.26 Mn |
| Jun 30, 2024 | 17.69 Mn |
| Mar 31, 2024 | 16.66 Mn |
| Dec 31, 2023 | 21.39 Mn |
| Sep 30, 2023 | 22.07 Mn |
| Jun 30, 2023 | 21.57 Mn |
| Mar 31, 2023 | 14.71 Mn |
| Dec 31, 2022 | 16.31 Mn |
| Sep 30, 2022 | 13.38 Mn |
| Jun 30, 2022 | 17.05 Mn |
| Mar 31, 2022 | 15.23 Mn |
| Dec 31, 2021 | 14.41 Mn |
API Access
Eton Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ETON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ETON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ETON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();